Article thumbnail

A high concentration of genistein down-regulates activin A, Smad3 and other TGF-β pathway genes in human uterine leiomyoma cells

By Xudong Di, Danica M.K. Andrews, Charles J. Tucker, Linda Yu, Alicia B. Moore, Xiaolin Zheng, Lysandra Castro, Tonia Hermon, Hang Xiao and Darlene Dixon

Abstract

Previously, we found that high doses of genistein show an inhibitory effect on uterine leiomyoma (UtLM) cell proliferation. In this study, using microarray analysis and Ingenuity Pathways Analysis™, we identified genes (up- or down-regulated, ≥ 1.5 fold, P ≤ 0.001), functions and signaling pathways that were altered following treatment with an inhibitory concentration of genistein (50 µg/ml) in UtLM cells. Downregulation of TGF-β signaling pathway genes, activin A, activin B, Smad3, TGF-β2 and genes related to cell cycle regulation, with the exception of the upregulation of the CDK inhibitor P15, were identified and validated by real-time RT-PCR studies. Western blot analysis further demonstrated decreased protein expression of activin A and Smad3 in genistein-treated UtLM cells. Moreover, we found that activin A stimulated the growth of UtLM cells, and the inhibitory effect of genistein was partially abrogated in the presence of activin A. Overexpression of activin A and Smad3 were found in tissue samples of leiomyoma compared to matched myometrium, supporting the contribution of activin A and Smad3 in promoting the growth of UtLM cells. Taken together, these results suggest that down-regulation of activin A and Smad3, both members of the TGF-β pathway, may offer a mechanistic explanation for the inhibitory effect of a high-dose of genistein on UtLM cells, and might be potential therapeutic targets for treatment of clinical cases of uterine leiomyomas

Topics: Original Article
Publisher: Korean Society for Biochemistry and Molecular Biology
OAI identifier: oai:pubmedcentral.nih.gov:3349910
Provided by: PubMed Central

Suggested articles

Citations

  1. (2000). A review of in vitro and in vivo data. Acta Pol Pharm
  2. (2005). Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells. Cancer Res
  3. Activin receptor signaling.
  4. (2012). carcinogenic pathways identified by gene expression analysis of peritoneal mesotheliomas following chemical treatment in F344 rats.
  5. Combined with a cDNA microarray analysis. Endothelium 2006;13:249-66 Polkowski K, Mazurek AP. Biological properties of genistein.
  6. (2006). Concentration-dependent effects of a selective estrogen receptor modulator raloxifene on proliferation and apoptosis in human uterine leiomyoma cells cultured in vitro. Hum Reprod
  7. (2007). Increased expression of latent TGF-beta binding protein-1 and fibrillin-1 in human uterine leiomyomata. Mol Hum Reprod
  8. (2008). Microarray study of gene expression in uterine leiomyoma. Exp Oncol

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.